Sartorius Aktiengesellschaft (FRA:SRT4)

Germany · Delayed Price · Currency is EUR

39.40

+1.60 (4.23%)

At close: Dec 4, 2025

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
EMEA Revenue	1.43B	1.39B	Log In	Log In	Log In	Upgrade
Americas Revenue	1.24B	1.20B	Log In	Log In	Log In	Upgrade
Asia Pacific Revenue	802.60M	792.30M	Log In	Log In	Log In	Upgrade

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Bioprocess Solutions Revenue	2.79B	2.69B	Log In	Log In	Log In	Upgrade
Lab Products & Services Revenue	673.70M	690.50M	Log In	Log In	Log In	Upgrade

EBITDA

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Bioprocess Solutions Underlying EBITDA	851.50M	787.20M	Log In	Log In	Log In	Upgrade
Lab Products & Services Underlying EBITDA	149.70M	158.10M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2019
Bioprocess Solutions Order Intake	2.69B	Log In	Log In	Log In	Upgrade
Lab Products & Services Order Intake	684.40M	Log In	Log In	Log In	Upgrade
Total Order Intake	3.38B	Log In	Log In	Log In	Upgrade